{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "earningsTimestamp": 1683145800, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -3.65, "epsForward": -3.26, "epsCurrentYear": -3.98, "priceEpsCurrentYear": -0.8040201, "sharesOutstanding": 8183300, "bookValue": 7.207, "fiftyDayAverage": 3.3338, "fiftyDayAverageChange": -0.13380003, "fiftyDayAverageChangePercent": -0.04013439, "twoHundredDayAverage": 5.5704, "twoHundredDayAverageChange": -2.3704002, "twoHundredDayAverageChangePercent": -0.425535, "marketCap": 26457312, "forwardPE": -0.9815951, "priceToBook": 0.4440128, "currency": "USD", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": 1.9108262, "regularMarketPrice": 3.2, "firstTradeDateMilliseconds": 1321021800000, "priceHint": 4, "exchange": "NGM", "shortName": "Lumos Pharma, Inc.", "longName": "Lumos Pharma, Inc.", "messageBoardId": "finmb_256380672", "regularMarketChange": 0.059999943, "regularMarketTime": 1684180788, "regularMarketDayHigh": 3.47, "regularMarketDayRange": "3.19 - 3.47", "regularMarketDayLow": 3.19, "regularMarketVolume": 15035, "regularMarketPreviousClose": 3.14, "bid": 0.0, "ask": 0.0, "bidSize": 14, "askSize": 8, "fullExchangeName": "NasdaqGM", "financialCurrency": "USD", "regularMarketOpen": 3.21, "averageDailyVolume3Month": 11231, "averageDailyVolume10Day": 13290, "fiftyTwoWeekLowChange": 0.25, "fiftyTwoWeekLowChangePercent": 0.084745765, "fiftyTwoWeekRange": "2.95 - 9.56", "fiftyTwoWeekHighChange": -6.3600006, "fiftyTwoWeekHighChangePercent": -0.665272, "fiftyTwoWeekLow": 2.95, "fiftyTwoWeekHigh": 9.56, "dividendDate": 1584576000, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.0 - Buy", "tradeable": false, "cryptoTradeable": false, "displayName": "Lumos Pharma", "symbol": "LUMO"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "4200 Marathon Boulevard", "address2": "Suite 200", "city": "Austin", "state": "TX", "zip": "78756", "country": "United States", "phone": "512 215 2630", "website": "https://lumos-pharma.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its primary product candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 3 clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.", "fullTimeEmployees": 32, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard J. Hawkins", "age": 73, "title": "Founder, CEO & Chairman", "yearBorn": 1949, "fiscalYear": 2022, "totalPay": {"raw": 975723, "fmt": "975.72k", "longFmt": "975,723"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 34734, "fmt": "34.73k", "longFmt": "34,734"}}, {"maxAge": 1, "name": "Dr. John C. McKew Ph.D.", "age": 58, "title": "Chief Scientific Officer & Pres", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 943463, "fmt": "943.46k", "longFmt": "943,463"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 18704, "fmt": "18.7k", "longFmt": "18,704"}}, {"maxAge": 1, "name": "Ms. Lori D. Lawley CPA", "age": 38, "title": "CFO & Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2022, "totalPay": {"raw": 596565, "fmt": "596.57k", "longFmt": "596,565"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Lisa  Miller", "title": "Sr. Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Bradley J. Powers J.D.", "age": 43, "title": "Chief Compliance Officer & Gen. Counsel", "yearBorn": 1979, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Carl W. Langren", "age": 67, "title": "Consultant", "yearBorn": 1955, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Aaron  Schuchart B.B.A., CPA, M.B.A.", "age": 57, "title": "Chief Bus. Officer", "yearBorn": 1965, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David B. Karpf B.A., M.D.", "age": 67, "title": "Chief Medical Officer", "yearBorn": 1955, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eddie L. Varnado M.B.A.", "title": "VP of Fin. & Corp. Controller", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}